Company intelligence / Profile preview
Orient EuroPharma
Taipei, Taipei City, Taiwanoepgroup.com ↗
- Ownership
- Public · 4120
- Development stage
- Other
01
Overview
Orient EuroPharma has a diversified portfolio with commercialized products in pharmaceuticals, nutritionals, dermo-cosmetics, and healthcare. Its R&D pipeline includes late-stage assets such as Multikine for head and neck cancer (Phase III), NC‑6004 for oncology indications (Phase III), ASC-J9 targeting androgen receptor degradation for prostate cancer or related conditions (completed Phase IIb), and 2ccPA for osteoarthritis of the knee in early clinical development. The company also recently launched Isotretor for acne under Taiwan's 505(b)(2) pathway.
- Therapeutic areas
- PsychiatryRheumatologyOncologyNeurology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Dairy Goat Co-operatives New Zealand (Karihome infant formula brand partnership)TissueTech™ (regenerative medicine ophthalmology collaboration)
04
Financials
- Market cap
- $112M
- Total revenue
- $140.3M
- Enterprise value
- $168.8M
Beyond the preview
Go deeper on Orient EuroPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orient EuroPharma.